A detailed history of Abacus Planning Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 21,902 shares of PFE stock, worth $649,613. This represents 0.12% of its overall portfolio holdings.

Number of Shares
21,902
Previous 26,559 17.53%
Holding current value
$649,613
Previous $737,000 16.96%
% of portfolio
0.12%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $117,635 - $137,847
-4,657 Reduced 17.53%
21,902 $612,000
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $25,372 - $29,135
980 Added 3.83%
26,559 $737,000
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $12,594 - $16,359
-482 Reduced 1.85%
25,579 $736,000
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $53,205 - $62,191
-1,658 Reduced 5.98%
26,061 $864,000
Q2 2023

Jul 06, 2023

BUY
$36.12 - $41.79 $41,863 - $48,434
1,159 Added 4.36%
27,719 $1.02 Million
Q1 2023

Apr 17, 2023

BUY
$39.39 - $51.28 $748 - $974
19 Added 0.07%
26,560 $1.08 Million
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $8,141 - $10,627
-195 Reduced 0.73%
26,541 $0
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $26,168 - $31,945
598 Added 2.29%
26,736 $1.17 Million
Q2 2022

Jul 18, 2022

BUY
$46.53 - $55.17 $10,701 - $12,689
230 Added 0.89%
26,138 $1.37 Million
Q1 2022

Apr 13, 2022

SELL
$45.75 - $56.69 $1,372 - $1,700
-30 Reduced 0.12%
25,908 $1.34 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $69,334 - $102,777
1,678 Added 6.92%
25,938 $1.53 Million
Q3 2021

Oct 19, 2021

BUY
$39.25 - $50.42 $6,868 - $8,823
175 Added 0.73%
24,260 $1.04 Million
Q2 2021

Jul 20, 2021

SELL
$35.91 - $40.68 $151,971 - $172,157
-4,232 Reduced 14.95%
24,085 $943,000
Q1 2021

Apr 27, 2021

BUY
$33.49 - $37.77 $32,351 - $36,485
966 Added 3.53%
28,317 $1.03 Million
Q4 2020

Feb 01, 2021

BUY
$33.47 - $42.56 $10,308 - $13,108
308 Added 1.14%
27,351 $1.01 Million
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $9,271 - $10,877
292 Added 1.09%
27,043 $992,000
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $9,096 - $11,035
-302 Reduced 1.12%
26,751 $875,000
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $3,513 - $5,020
-130 Reduced 0.48%
27,053 $883,000
Q4 2019

Jan 30, 2020

SELL
$32.92 - $37.36 $4,839 - $5,491
-147 Reduced 0.54%
27,183 $1.07 Million
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $159,655 - $207,026
4,914 Added 21.92%
27,330 $982,000
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $56,135 - $63,027
-1,518 Reduced 6.34%
22,416 $971,000
Q1 2019

Apr 25, 2019

BUY
$37.5 - $41.2 $38,175 - $41,941
1,018 Added 4.44%
23,934 $1.02 Million
Q4 2018

Feb 15, 2019

BUY
$38.47 - $43.86 $670,147 - $764,041
17,420 Added 316.96%
22,916 $1 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $670,147 - $764,041
-17,420 Reduced 76.02%
5,496 $505,000
Q4 2018

Jan 25, 2019

BUY
$38.47 - $43.86 $41,355 - $47,149
1,075 Added 4.92%
22,916 $1 Million
Q3 2018

Oct 31, 2018

SELL
$34.47 - $41.81 $79,556 - $96,497
-2,308 Reduced 9.56%
21,841 $962,000
Q2 2018

Jul 27, 2018

BUY
$32.98 - $35.16 $20,546 - $21,904
623 Added 2.65%
24,149 $876,000
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $171,197 - $198,612
5,365 Added 29.54%
23,526 $835,000
Q4 2017

Mar 06, 2018

BUY
$33.26 - $35.29 $604,034 - $640,901
18,161
18,161 $658,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Abacus Planning Group, Inc. Portfolio

Follow Abacus Planning Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.